By Mary Hightower
University of Arkansas Division of Agriculture 

Fast Facts 

  • Jury not swayed by plaintiffs’ non-failure-to-warn arguments
  • Plaintiffs have 30 days to file post-trial motions 

FAYETTEVILLE, Ark. — A Missouri jury found in favor of Monsanto in the first liability trial involving Roundup, the company’s glyphosate-based pesticide, held in the wake of the U.S. Supreme Court’s failure-to-warn decision in June.

A head-and-shoulders portrait of a woman with a warm, pleasant smile, looking directly at the camera against a plain, light grey background. She has brown, shoulder-length wavy hair with full bangs and wears round, tortoiseshell-patterned cat-eye glasses with thin metal rims. Her outfit consists of a light lavender-purple button-up knit cardigan worn open over a textured, ribbed cream-colored tank top. She is accessorized with thin silver hoop earrings and a small, subtle silver nose stud.

Brigit Rollins of the National Agricultural Law Center updates the latest in the failure-to-warn saga surrounding pesticides. (UADA image)

The plaintiffs have 30 days to file any post-trial motions.  

The Oct. 29 verdict came in the case of Theresa Aretino, et al. v. Monsanto Company, which was heard in the 21st Judicial Circuit Court of Missouri. 

In June, the SCOTUS ruled that the Federal Insecticide, Fungicide, and Rodenticide Act, or FIFRA, expressly pre-empts a state-law failure-to-warn claim against Monsanto, because such a claim would require the company to add a cancer warning to Roundup’s label that is not part of the label approved by the federal Environmental Protection Agency. 

“As in previous Roundup liability trials, the three plaintiffs alleged that exposure to Roundup and its active ingredient glyphosate caused them to develop cancer,” said Brigit Rollins, staff attorney for the National Agricultural Law Center. “Unlike previous Roundup trials, the Missouri plaintiffs were unable to raise state law failure-to-warn claims because Monsanto Co. vs. Durnell held that federal pesticide law preempts such arguments.” 

In the Missouri case, plaintiffs focused on allegations that Roundup was defectively designed and that Monsanto inadequately tested the pesticide’s formulation and minimized research suggesting possible cancer risks, Rollins said.  

“The trial centered on competing scientific assessments, including EPA’s conclusion that glyphosate is not likely to cause cancer and the International Agency for Research on Cancer’s classification of the chemical as a probable human carcinogen,” she said.  

To read the full news release, click here.

Share: